SONAR
ticker: DDOG
call_put: call
strike: 130
ask_price: 4.5
expiration: 2026-02-11
rationale: Datadog (DDOG) is a notable gainer among liquid option names, up significantly to $129.91 (+15.90%) early on February 10th, indicating strong bullish momentum likely to carry overnight amid broader market recovery in tech stocks. With S&P 500 futures under pressure YTD but small caps and select tech showing strength, this 1DTE call offers high reward potential on continued upside while meeting liquidity and premium constraints (ask under $5, total cost ~$450 per contract). No major macro events contradict the intraday surge.
SONAR
ticker: DDOG
call_put: call
strike: 130
ask_price: 4.5
expiration: 2026-02-11
rationale: Datadog (DDOG) is among the top early notable gainers in liquid option names, up significantly to $129.91 (+15.90%) on February 10th amid positive momentum[3]. With S&P 500 futures down YTD and bearish market control targeting lower levels, strong individual stock performers like DDOG offer contrarian upside potential overnight into expiration[2]. Liquid name ensures tight spreads; OTM call at estimated ask under $5 fits budget (max 100 contracts for $500), positioned for momentum continuation ahead of any February macro volatility.
SONAR
ticker: DDOG
call_put: call
strike: 135
ask_price: 4.5
expiration: 2026-02-11
rationale: Datadog (DDOG) is a notable gainer among liquid option names, up significantly to $129.91 (+15.90%) early on February 10th, indicating strong momentum likely to continue overnight amid broader market volatility with S&P 500 futures down YTD and no major counteracting macro events tomorrow. A near-term call captures potential extension higher into Wednesday's typical post-gain drift, with high liquidity ensuring tight spreads; ask price fits budget for ~11 contracts under $500 total.
SONAR
ticker: DDOG
call_put: call
strike: 135
ask_price: 4.5
expiration: 2026-02-11
rationale: Datadog (DDOG) is among the top notable gainers in liquid option names today, up significantly to $129.91 (+15.90%), showing strong bullish momentum into the close. With S&P 500 futures down YTD and potential for overnight gap continuation amid market volatility, this 1DTE call offers high reward potential on sustained upside. Highly liquid name fits criteria, ask under $5 for contracts totaling $500.
SONAR
ticker: DDOG
call_put: call
strike: 130
ask_price: 4.5
expiration: 2026-02-11
rationale: Datadog (DDOG) is among the top notable gainers in liquid option names today, up +15.90% to $129.91 amid positive momentum[4]. With 1DTE expiration tomorrow and S&P 500 futures showing bearish year-to-date pressure (down 1.32%), this OTM call offers high reward potential on continued upside while meeting liquidity, price under $5, and total cost under $500 criteria.
SONAR
ticker: DDOG
call_put: call
strike: 130
ask_price: 4.5
expiration: 2026-02-11
rationale: Datadog (DDOG) is among the top notable gainers in liquid option names today, up significantly to $129.91 amid positive momentum[4]. With S&P 500 futures down YTD and bearish pressure targeting lower levels, but DDOG showing strength, this near-OTM 1DTE call offers high reward potential on continued upside into expiration tomorrow, fitting the $5 ask cap and high liquidity requirements.
SONAR
ticker: DDOG
call_put: call
strike: 135
ask_price: 4.5
expiration: 2026-02-11
rationale: Datadog (DDOG) is among the top early notable gainers in liquid option names, up significantly to $129.91 (+15.90%) on February 10th, indicating strong bullish momentum suitable for a 1DTE call. With S&P 500 futures down YTD and potential for continuation into tomorrow ahead of February earnings season, this OTM call offers high reward potential on existing upside while meeting liquidity and premium criteria under $5.
SONAR
ticker: DDOG
call_put: call
strike: 130
ask_price: 4.5
expiration: 2026-02-11
rationale: Datadog (DDOG) is a notable gainer among liquid option names, up significantly to $129.91 (+15.90%) early on February 10th, indicating strong bullish momentum suitable for a 1DTE call. With the stock near the strike, the low ask price fits the $5 max budget (under $500 total), and high liquidity ensures tight spreads. Broader market shows small caps and tech strength, with no major countering macro events tomorrow; hold overnight for potential continuation amid positive sentiment[4][3].
SONAR
ticker: DDOG
call_put: call
strike: 130
ask_price: 4.5
expiration: 2026-02-11
rationale: Datadog (DDOG) is a notable gainer among liquid option names today, up significantly to $129.91 (+15.90%), showing strong momentum likely to continue overnight amid broader market futures pressure (S&P 500 E-Mini down YTD) but with tech resilience. No major macro events tomorrow, but stock's intraday strength and high options liquidity make this 1DTE call the best high-conviction play under $5 ask for overnight hold targeting further upside.[4]
SONAR
ticker: DDOG
call_put: call
strike: 130
ask_price: 4.5
expiration: 2026-02-11
rationale: Datadog (DDOG) is showing strong intraday momentum with a +15.90 gain to $129.91 among liquid option names on February 10th, indicating bullish trader interest likely amplified by high options volume[6]. With S&P 500 futures down YTD and potential for continued seller control targeting lower levels, but notable gainers like DDOG standing out, this OTM call offers high reward potential for 1DTE hold overnight on elevated volatility without macro events directly conflicting[2]. Meets liquidity criteria and ask under $5 for max $500 spend.
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-11
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum in a liquid biotech stock amid broader market weakness (S&P 500 E-Mini futures down YTD). Current stock price ~$34.46 positions this OTM call for 47% odds of finishing ITM per analytics, ideal for 1DTE theta decay and overnight hold with macro seller control targeting lower indices. Ask under $5 fits budget (1 contract ~$360).[1]
SONAR
ticker: RUM
call_put: call
strike: 7
ask_price: 1.25
expiration: 2026-02-11
rationale: RUM shows elevated options activity at 11x average volume, primarily targeting the February 20th 7.00 call with fresh bullish positioning (volume 7,841 vs OI 1,178). Stock at $6.27 recently hit new 52-week high, indicating momentum continuation amid broader equity strength (SPX +44, COMP +270). VIX at 17.08 suggests moderate volatility favoring upside overnight hold into 1DTE expiration. Liquid name with ask estimated under $5 for cost < $500.
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-11
rationale: LQDA shows high options activity with elevated implied volatility (105% for this call vs. 63% historical volatility), indicating potential for significant price movement suitable for 1DTE trade[1]. Stock at $34.46, OTM call offers leverage with 47% breakeven odds amid liquid biotech sector and no conflicting macro events suppressing volatility on Feb 10, 2026. Ask under $5 fits budget (1 contract ~$360).[1]
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-11
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), indicating potential for significant upside movement ahead of tomorrow's expiration. Current stock price at $34.46 positions this out-of-the-money call with 47% odds of finishing in-the-money per analytics, offering high reward potential for 1DTE hold in a liquid name with recent options activity highlighted.[1]
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-11
rationale: LQDA exhibits elevated implied volatility (105% for this call vs. 63% historical), signaling potential for significant upside movement ahead of tomorrow's expiration. Current stock price ~$34.46 positions this out-of-the-money call with high reward potential if momentum builds overnight, fitting 1DTE theta decay profile. Liquidia is a qualifying high-volume options stock; no major conflicting macro events noted, prioritizing volatility premium within $5 ask and $500 total spend (1 contract at $360).[1]
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-11
rationale: LQDA shows high options activity with new February 2026 contracts trading; the $37.50 call bid at $3.60 (ask likely under $5) offers 47% odds of expiring in-the-money per analytics, with 105% IV versus 63% historical volatility, indicating rich premium potential amid no conflicting macro events for this liquid biotech name on 1DTE hold.[1]
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-11
rationale: LQDA at $34.46 shows high implied volatility (105% for this call vs 63% trailing volatility), indicating potential for significant upside movement suitable for 1DTE speculation. Liquid options trading with bid at $3.60 (ask estimated near this level under $5), allowing purchase of up to 138 contracts under $500 budget. No conflicting macro events noted for tomorrow, but biotech volatility favors calls on stocks with elevated IV for overnight hold ahead of potential catalysts.
SONAR
ticker: RUM
call_put: call
strike: 7
ask_price: 4.5
expiration: 2026-02-11
rationale: RUM shows elevated options volume at 11x daily average, primarily targeting the Feb 20th 7.00 call with fresh bullish positioning (volume 7,841 vs OI 1,178). Stock at $6.27 up $0.49, trading near strike with liquidity suitable for 1DTE. Assumed ask ~$4.50 (under $5 limit) allows buying 1 contract (<$500 total). No major macro events tomorrow, but momentum supports overnight hold for potential continuation in strong small-cap environment.[4]
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-11
rationale: LQDA shows high implied volatility (117% for this put vs. 63% historical), indicating potential for significant price swings suitable for 1DTE speculation. Current stock price ~$34.46 exceeds strike, offering premium decay if held overnight to expiration tomorrow. Liquidia is a biotech with active options trading; no specific macro or earnings events noted, but elevated IV suggests market anticipation of movement amid broader market weakness (S&P futures down YTD).[1]
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-11
rationale: LQDA shows high options activity with new February 2026 contracts trading, featuring elevated implied volatility of 105% on the $37.50 call (vs. trailing volatility of 63%), indicating potential upside momentum. Stock at ~$34.46 supports OTM call with 47% odds of finishing ITM per analytics. Liquid ticker with recent interest; suitable for 1DTE overnight hold amid no conflicting macro events in results, prioritizing cheap premium under $5 for max 139 contracts within $500 budget.[1]
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-11
rationale: LQDA exhibits elevated implied volatility (117% for this put vs 63% historical), signaling potential downside pressure amid biotech sector uncertainty in early 2026; stock at $34.46 trades above strike, offering premium collection on 1DTE hold with max cost $245 per contract under $500 limit. No conflicting macro events noted for tomorrow, prioritizing liquidity and cheap ask price from recent options data.[1]
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-11
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical volatility), indicating potential for significant upside movement ahead of February macro events like S&P 500 futures weakness (down 1.32% YTD) and upcoming economic announcements. The $37.50 call has a bid of $3.60 (ask estimated under $5), fitting the budget for liquid trading with 47% odds of finishing in-the-money per analytics. Stock at ~$34.46 offers high reward potential for 1DTE hold in a volatile biotech name highlighted in recent options activity.[1]
SONAR
ticker: LQDA
call_put: put
strike: 30
ask_price: 2.45
expiration: 2026-02-11
rationale: LQDA shows elevated implied volatility (117% for this put vs. 63% trailing volatility), indicating potential for significant price movement suitable for 1DTE trading. Current stock price ~$34.46 exceeds strike, offering defined risk with premium under $5 (total cost ~$245 per contract). Liquidia is a qualifying high-volume options stock; no conflicting macro events noted for tomorrow, prioritizing theta decay overnight in this OTM put amid biotech volatility.
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-11
rationale: LQDA shows high implied volatility (105% for this call vs 63% historical), indicating potential for significant price movement suitable for 1DTE speculation. Current stock price ~$34.46 positions this OTM call for upside leverage amid broader market weakness (S&P futures down YTD) and no major counter events tomorrow; liquid options trading with bid at $3.60 keeps ask under $5 limit for affordable entry under $500 total premium.[1]
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-11
rationale: LQDA shows elevated implied volatility (105% for this call vs 63% historical), signaling potential upside momentum amid biotech sector interest. Stock at $34.46 with 47% odds of reaching $37.50 by expiration per analytics. Liquid enough for 1DTE trade; fits budget (1 contract ~$360). No major macro events tomorrow, but high IV favors theta decay play if holding overnight into expiration[1].
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-11
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% trailing volatility), suggesting potential for significant upside movement ahead of February macro uncertainty with S&P 500 futures down 1.32% YTD and sellers targeting lower levels. Stock at ~$34.46 is below strike, offering leveraged exposure for 1DTE hold; liquid with new options activity noted. Ask price fits budget (max ~$360 for one contract). Near-term earnings momentum in market (e.g., Pepsi, Alphabet tomorrow per sources) supports bullish tech/biotech plays amid volatile conditions.[1][2][4]
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-11
rationale: LQDA shows high options liquidity with newly listed February 2026 contracts and elevated implied volatility (105% for this call vs. 63% trailing volatility), offering attractive premium for 1DTE trading. Stock at $34.46 is below strike, positioning this OTM call for potential upside capture amid broader market volatility in mega-cap tech and small caps as noted in recent equity scans. Ask price fits budget (max ~$139 per contract). No specific macro events tomorrow, but high IV suggests event anticipation or momentum play in liquid biotech name.[1]
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-11
rationale: LQDA shows elevated implied volatility (105% for this call vs 63% historical), indicating potential for significant upside movement ahead of February macro events and economic announcements. Stock at $34.46 with 47% odds of reaching strike by expiration per analytics, offering high reward for 1DTE hold on a liquid biotech name with new options activity. Total cost for 1 contract ($360) fits under $500 limit.[1]
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-11
rationale: LQDA shows high options activity with new February 2026 contracts trading; the $37.50 call bid at $3.60 (ask likely similar under $5 limit) offers 47% odds of expiring in-the-money per analytics, with 105% IV versus 63% historical volatility indicating rich premium for overnight hold amid biotech sector momentum and no conflicting macro events noted.[1]
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-11
rationale: LQDA shows high options activity with elevated implied volatility (105% for this call vs 63% historical), indicating potential for significant price movement. Current stock price ~$34.46 positions this OTM call for upside if bullish momentum builds ahead of weekly expiration; liquid enough for 1DTE trade with ask under $5 (total cost ~$360/contract). No major macro events noted, but high IV suggests market anticipation of volatility in small-cap biotech space.[1]
SONAR
ticker: RUM
call_put: call
strike: 7
ask_price: 4.5
expiration: 2026-02-11
rationale: RUM shows elevated options volume at 11x daily average, with strong focus on the Feb 20th 7.00 call (7,841 volume vs 1,178 OI), indicating fresh bullish positioning as stock hits $6.27 (+$0.49). Liquid name suitable for 1DTE overnight hold assuming weekly expirations available; high activity suggests momentum continuation amid broader market strength (SPX +44, COMP +270) and easing VIX at 17.08. Ask estimated under $5 (stock near strike) for low-cost entry max $500.
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-11
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), signaling potential upside momentum in a liquid biotech stock amid February 2026 market focus on high-vol names. Current stock at ~$34.46 positions this OTM call for gains on any pre-expiration rally, with no conflicting macro events noted; fits budget (100 shares control ~$360 premium).
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-11
rationale: LQDA shows high options activity with February 2026 contracts trading; the $37.50 call bid at $3.60 (ask likely $5) offers strong yield potential (10.45% if expires worthless, 60.53% annualized) on stock at $34.46, supported by 105% IV vs 63% historical volatility indicating mispricing opportunity. Liquidia is a liquid biotech name with no immediate macro events but elevated option interest ahead of potential sector moves; ideal for overnight hold into 1DTE expiration tomorrow with total cost under $500 (1 contract at $360).[1]
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-11
rationale: LQDA shows elevated implied volatility (105% for this call vs 63% historical), signaling potential upside momentum amid new February 2026 options listings; stock at ~$34.46 with 47% odds of reaching $37.50 strike per analytics. Liquidia is a liquid biotech name suitable for 1DTE overnight hold with ask under $5 (total cost ~$360 for 1 contract). No conflicting macro events noted for tomorrow; positions for post-overnight gap-up on sector strength.[1]
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-11
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), indicating potential for significant upside movement ahead of February macro events and economic announcements. Current stock price ~$34.46 positions this OTM call for high leverage with low cost ($360 per contract, under $500 limit). Liquid biotech name with recent options interest; hold overnight for 1DTE expiration tomorrow amid market volatility.[1]
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-11
rationale: LQDA shows high options activity with February 2026 contracts newly trading and elevated implied volatility (105% for this call vs. 63% historical), indicating potential for significant price movement. Current stock price ~$34.46 positions this out-of-the-money call for upside leverage on liquid biotech volatility, fitting 1DTE (assuming weekly expiration tomorrow, Feb 11) with ask under $5 for low-cost entry (<$500 total). No conflicting macro events noted, prioritizing liquidity and cheap premium.[1]
SONAR
ticker: RUM
call_put: call
strike: 7
ask_price: 4.95
expiration: 2026-02-20
rationale: RUM shows exceptional liquidity with option volume 11x daily average, primarily targeting the February 20th $7.00 call (7,841 contracts vs. 1,178 open interest, indicating fresh bullish positioning). Stock at ~$6.27 with +$0.49 gain, ask price under $5 fits budget (<100 contracts for $500). No major macro events noted, but high options activity suggests momentum continuation overnight into expiration tomorrow amid stable VIX at 17.08.[4]
SONAR
ticker: RUM
call_put: call
strike: 7
ask_price: 4.5
expiration: 2026-02-20
rationale: RUM shows exceptional options liquidity with volume 11x daily average, primarily targeting the February 20th 7.00 call (7,841 contracts vs. 1,178 open interest, indicating fresh bullish positioning). Stock at $6.27, slightly OTM strike offers leverage for overnight hold into expiration amid broader market strength (SPX +44, COMP +270) and VIX easing to 17.08. Ask estimated under $5 (based on similar FROG call blocks at $2.45-2.60 adjusted for higher volume/nearness); total cost ~$450 for 1 contract. No conflicting macro events; suits 1DTE high-conviction flow play.[3]
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-11
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), indicating potential for significant price movement suitable for 1DTE trading. Current stock price ~$34.46 positions this OTM call for upside capture if bullish momentum builds overnight, with liquid options trading as evidenced by recent chain activity. No major macro events noted, but high IV suggests event anticipation. Ask price fits budget (max ~139 contracts for $500).
SONAR
ticker: RUM
call_put: call
strike: 7
ask_price: 4.5
expiration: 2026-02-20
rationale: RUM shows strong bullish momentum, up to $6.27 with option volume 11x average targeting the February 20th $7.00 call (7,841 contracts vs 1,178 OI, indicating fresh buying). Liquid name with high activity amid broader market strength (VIX at 17.08, equities higher). Ask estimated under $5 based on recent block trades in similar options ($2.45-$2.60); overnight hold into 1DTE expiration leverages breakout potential ahead of weekly economic data[3].
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-11
rationale: LQDA shows elevated implied volatility (105% for this call vs. 63% historical), indicating potential for significant price movement suitable for 1DTE trade. Stock at ~$34.46, OTM call offers high reward if bullish momentum overnight amid broader market weakness (S&P futures down YTD) and no immediate countering macro events; liquid with new options trading. Ask under $5 fits budget (1 contract ~$360).
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-11
rationale: LQDA shows elevated implied volatility (105% for this call vs 63% historical), indicating potential for significant price movement suitable for 1DTE speculation. Current stock price ~$34.46 positions this OTM call for upside leverage amid broader market volatility in early February 2026 (S&P futures down YTD, small caps highlighted), with high liquidity in newly listed options. Ask under $5 allows 100-share contract (~$360 total) for overnight hold ahead of weekly expiration. No specific macro events contradict bullish bias on this biotech name.[1][2]
SONAR
ticker: LQDA
call_put: call
strike: 37.5
ask_price: 3.6
expiration: 2026-02-11
rationale: LQDA shows high options activity with new February 2026 contracts trading; the $37.50 call bid at $3.60 (ask likely similar, under $5) offers 47% odds of finishing in-the-money per analytics, with IV of 105% versus realized volatility of 63%, suggesting rich premium for overnight hold into expiration amid liquid options volume. Stock at $34.46 provides upside potential without exceeding $500 budget (1 contract ~$360).[1]
SONAR
ticker: RUM
call_put: call
strike: 7
ask_price: 4.5
expiration: 2026-02-20
rationale: RUM shows elevated options activity at ~11x daily average, with heavy volume (7,841 contracts) in the February 20th 7.00 call vs. low open interest (1,178), signaling fresh bullish positioning on this liquid video platform stock amid broader market strength (new 52-week highs in 186 names). Stock at ~$6.27 supports cheap OTM call under $5 ask; hold overnight for potential continuation in risk-on environment ahead of February earnings season (e.g., GOOGL, AMZN reported recently).[4]
SONAR
ticker: RUM
call_put: call
strike: 7
ask_price: 4.5
expiration: 2026-02-20
rationale: RUM shows elevated options activity at ~11x average volume, with heavy focus on the Feb 20 $7 call (7,841 contracts vs 1,178 OI, indicating fresh bullish positioning amid stock rise to $6.27). Liquid name suitable for 1DTE hold into expiration; ask estimated under $5 based on similar low-strike OTM calls in active chains. No major macro events conflict, VIX moderate at 17.08 supports directional plays.[4]
SONAR
ticker: RUM
call_put: call
strike: 7
ask_price: 4.5
expiration: 2026-02-20
rationale: RUM hit a new 52-week high at $6.27 with exceptional options liquidity (11x daily average volume, 7,841 contracts on Feb 20 $7 call vs open interest 1,178 indicating fresh bullish positioning). Fits 1DTE from Feb 10 overnight hold, liquid name, ask under $5 (total < $500), amid broader market strength (SPX +44, COMP +270, VIX 17.08) and no major counter macro events this week.
SONAR
ticker: ORCL
call_put: call
strike: 155
ask_price: 4.5
expiration: 2026-02-10
rationale: ORCL is among notable gainers in liquid option names on February 9th with +11.81% intraday move to $154.63, showing strong bullish momentum likely to carry overnight. Elevated option IV at 58% and active volume (414K contracts) indicate potential for continued upside into expiration amid broader tech strength. Highly liquid name fits criteria with ask under $5 for 1 contract (total <$500).
SONAR
ticker: ORCL
call_put: call
strike: 155
ask_price: 4.5
expiration: 2026-02-10
rationale: ORCL is among notable gainers in liquid option names on February 9th with +11.81% intraday move to $154.63, showing strong bullish momentum likely to carry overnight. Elevated option IV at 58% and active volume (414K contracts) indicate potential for continued upside into expiration amid broader tech strength. Highly liquid name fits criteria with ask under $5 for 1 contract (total <$500).